CompletedPhase 2NCT04356716

Sildenafil for Treatment of Choroidal Ischemia

Studying Best vitelliform macular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Columbia University
Principal Investigator
Donald Jackson Coleman, MD, MD
Columbia University
Intervention
Sildenafil(drug)
Enrollment
22 enrolled
Eligibility
18 years · All sexes
Timeline
20142020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04356716 on ClinicalTrials.gov

Other trials for Best vitelliform macular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Best vitelliform macular dystrophy

← Back to all trials